Your session is about to expire
← Back to Search
PainTracker for Managing Opioid Use Disorder
N/A
Waitlist Available
Led By Jason Doctor, PhD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months
Awards & highlights
Study Summary
This trial will look at how well PainTracker can help clinicians manage aging patients on long-term opioid therapy by better targeting the risks of misuse and harm, while also addressing their comorbid conditions.
Who is the study for?
This trial is for patients aged 65 or older who are on long-term opioid therapy and registered within the Northwestern Medicine Chronic Opioid Use system. They must have seen a primary care doctor in the past year. People with active cancer diagnoses cannot participate.Check my eligibility
What is being tested?
The study tests PainTracker, which evaluates various issues related to pain management, against standard practices. It aims to see if focusing on comorbid conditions rather than just opioid misuse can lead to safer use patterns among elderly patients.See study design
What are the potential side effects?
Since this trial involves monitoring and guiding usage patterns rather than testing new medications, side effects are not a primary concern as they would be in drug trials.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 9 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Antidepressant orders
Referral rate to non-opioid care
Secondary outcome measures
Benzodiazepine prescribing
Clinician monthly milligram morphine equivalent (MME)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Current Opioid Misuse Measure (COMM) + PainTrackerExperimental Treatment1 Intervention
On a monthly basis, patients will receive both the abbreviated Current Opioid Misuse Measure (COMM) and PainTracker. PainTracker tracks multiple outcomes relevant to the treatment of chronic pain: pain severity, general activity interference, enjoyment of life interference, sleep (initiating and maintaining), depression, and anxiety.
Group II: Current Opioid Misuse Measure (COMM)Active Control1 Intervention
On a monthly basis, patients will receive the abbreviated Current Opioid Misuse Measure (COMM), a 6-item self-report screener to identify and monitor the risk of aberrant opioid-related behavior in chronic pain patients on opioid therapy. The COMM asks patients to report their behaviors over the past 30 days using a five-point Likert-type rating scale.
Find a Location
Who is running the clinical trial?
University of Southern CaliforniaLead Sponsor
905 Previous Clinical Trials
1,596,018 Total Patients Enrolled
4 Trials studying Pain
2,174 Patients Enrolled for Pain
Northwestern UniversityOTHER
1,585 Previous Clinical Trials
916,931 Total Patients Enrolled
46 Trials studying Pain
3,460 Patients Enrolled for Pain
National Institute on Aging (NIA)NIH
1,668 Previous Clinical Trials
28,004,764 Total Patients Enrolled
9 Trials studying Pain
2,122 Patients Enrolled for Pain
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any available slots to join this trial?
"At present, this clinical trial is not seeking any participants. The study was initially posted on August 9th 2023 and its information was last updated on September 25th of the same year. Despite this inactivity, 489 other medical trials are actively enrolling patients right now."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger